What is the share price of Narayana Hrudayalaya Ltd (NH) today?
The share price of NH as on 3rd June 2025 is ₹1753.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Narayana Hrudayalaya Ltd (NH) share?
The past returns of Narayana Hrudayalaya Ltd (NH) share are- Past 1 week: -0.63%
- Past 1 month: -1.72%
- Past 3 months: 20.88%
- Past 6 months: 39.05%
- Past 1 year: 47.66%
- Past 3 years: 169.79%
- Past 5 years: 490.80%
What are the peers or stocks similar to Narayana Hrudayalaya Ltd (NH)?
The peers or stocks similar to Narayana Hrudayalaya Ltd (NH) include:What is the dividend yield % of Narayana Hrudayalaya Ltd (NH) share?
The current dividend yield of Narayana Hrudayalaya Ltd (NH) is 0.26.What is the market cap of Narayana Hrudayalaya Ltd (NH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Narayana Hrudayalaya Ltd (NH) is ₹35463.26 Cr as of 3rd June 2025.What is the 52 week high and low of Narayana Hrudayalaya Ltd (NH) share?
The 52-week high of Narayana Hrudayalaya Ltd (NH) is ₹1871.60 and the 52-week low is ₹1080.What is the PE and PB ratio of Narayana Hrudayalaya Ltd (NH) stock?
The P/E (price-to-earnings) ratio of Narayana Hrudayalaya Ltd (NH) is 44.88. The P/B (price-to-book) ratio is 12.29.Which sector does Narayana Hrudayalaya Ltd (NH) belong to?
Narayana Hrudayalaya Ltd (NH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Narayana Hrudayalaya Ltd (NH) shares?
You can directly buy Narayana Hrudayalaya Ltd (NH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Narayana Hrudayalaya Ltd
NH Share Price
How to use scorecard? Learn more
NH Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
44.88 | 12.29 | 0.26% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
35.41 | 6.50 | 0.86% |
NH Analyst Ratings & Forecast
Detailed Forecast from 9 analysts
Price Upside
Earnings Growth
Rev. Growth
NH Company Profile
Narayana Hrudayalaya Ltd is engaged in operating a network of hospitals in India. The Company has hospitals in southern state of Karnataka and eastern India, as well as in western and central India.
Investor Presentation
View olderNH Similar Stocks (Peers)
Compare with peersNH Sentiment Analysis
NH Stock Summary · February 2025
The recent earnings call highlighted a cautiously optimistic outlook, driven by the operational launch of a new outpatient facility in the Cayman Islands, which is expected to enhance future revenue streams despite initial cost burdens. In India, new hospitals are showing improved EBITDA, particularly in Gurugram and Dharamshala, while operational efficiencies are being prioritized to manage costs effectively. However, challenges persist in attracting medical tourists and negotiating brownfield expansions, prompting a strategic focus on enhancing local healthcare accessibility. The company is also exploring innovative insurance products tailored for families and senior citizens, aiming to build long-term patient loyalty despite initial losses. Overall, a balanced approach to expansion and investment is being adopted, reflecting a commitment to operational excellence and financial discipline.
Key Points on Nh Stock
NH Stock Growth Drivers
7Operational Success of New Outpatient Facility
The new outpatient facility that commenced operations in December has shown positive initial responses, contributing
Improvement in Financial Performance
There has been a marked improvement in the financial performance of new hospitals, with combined
NH Stock Challenges
4Cost Escalation and Operational Readiness Challenges
The company is facing anticipated cost escalations as it approaches Q1, primarily due to increases
Underperformance in Capital Expenditure
The company has significantly underperformed in its capital expenditure (Capex) plans, having spent only INR
NH Forecasts
NH Forecast
Price
Revenue
Earnings
NH Share Price Forecast
All values in ₹
All values in ₹
NH Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
NH Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
NH
Income
Balance Sheet
Cash Flow
NH Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 1,887.72 | 2,301.51 | 2,877.59 | 3,151.57 | 2,610.53 | 3,735.88 | 4,590.22 | 5,093.44 | 5,575.82 | 5,644.26 | ||||||||||
Raw Materials | 438.88 | 566.63 | 687.10 | 722.36 | 665.45 | 920.72 | 1,012.27 | 1,112.31 | 4,214.95 | 4,282.51 | ||||||||||
Power & Fuel Cost | 49.90 | 65.08 | 77.98 | 81.19 | 73.52 | 83.63 | 94.04 | 104.79 | ||||||||||||
Employee Cost | 375.21 | 465.69 | 622.77 | 673.70 | 627.19 | 768.47 | 879.20 | 1,004.30 | ||||||||||||
Selling & Administrative Expenses | 138.91 | 184.55 | 234.88 | 851.54 | 700.68 | 869.01 | 1,073.34 | 1,199.25 | ||||||||||||
Operating & Other expenses | 641.97 | 784.68 | 943.30 | 381.84 | 333.87 | 404.69 | 485.66 | 430.26 | ||||||||||||
EBITDA | 242.85 | 234.88 | 311.56 | 440.94 | 209.82 | 689.36 | 1,045.71 | 1,242.53 | 1,360.87 | 1,361.75 | ||||||||||
Depreciation/Amortization | 79.92 | 99.95 | 137.36 | 185.80 | 183.53 | 183.48 | 210.04 | 242.14 | 278.11 | 278.86 | ||||||||||
PBIT | 162.93 | 134.93 | 174.20 | 255.14 | 26.29 | 505.88 | 835.67 | 1,000.39 | 1,082.76 | 1,082.89 | ||||||||||
Interest & Other Items | 27.58 | 54.57 | 80.80 | 93.84 | 82.35 | 76.09 | 84.09 | 111.86 | 146.41 | 146.41 | ||||||||||
PBT | 135.35 | 80.36 | 93.40 | 161.30 | -56.06 | 429.79 | 751.58 | 888.53 | 936.35 | 936.48 | ||||||||||
Taxes & Other Items | 52.29 | 29.02 | 34.23 | 42.39 | -41.77 | 87.85 | 145.33 | 99.26 | 146.20 | 146.34 | ||||||||||
Net Income | 83.06 | 51.34 | 59.17 | 118.91 | -14.29 | 341.94 | 606.25 | 789.27 | 790.15 | 790.14 | ||||||||||
EPS | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.90 | 38.66 | ||||||||||
DPS | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 1.00 | 2.50 | 4.00 | 4.50 | 4.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.35 | 0.17 | 0.00 | 0.06 | 0.08 | 0.10 | 0.12 | 0.10 |
NH Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
NH Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Narayana Hrudayalaya Ltd | 44.88 | 12.29 | 0.26% |
Max Healthcare Institute Ltd | 104.06 | 13.31 | 0.13% |
Apollo Hospitals Enterprise Ltd | 68.77 | 13.58 | 0.40% |
Fortis Healthcare Ltd | 70.44 | 6.37 | 0.14% |
NH Stock Price Comparison
Compare NH with any stock or ETFNH Shareholdings
NH Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
NH Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
NH Shareholding Pattern
NH Shareholding History
Mutual Funds Invested in NH
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Narayana Hrudayalaya Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2539% | Percentage of the fund’s portfolio invested in the stock 1.91% | Change in the portfolio weight of the stock over the last 3 months 0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/137 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9908% | Percentage of the fund’s portfolio invested in the stock 0.36% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 84/151 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7080% | Percentage of the fund’s portfolio invested in the stock 3.04% | Change in the portfolio weight of the stock over the last 3 months 0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 12/40 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing NH stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Narayana Hrudayalaya Ltd
NH Events
NH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
NH Upcoming Dividends
No upcoming dividends are available
NH Past Dividends
Cash Dividend
Ex DateEx DateAug 2, 2024
Dividend/Share
₹4.00
Ex DateEx Date
Aug 2, 2024
Cash Dividend
Ex DateEx DateJul 7, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Jul 7, 2023
Cash Dividend
Ex DateEx DateAug 22, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Aug 22, 2022
Cash Dividend
Ex DateEx DateMar 11, 2020
Dividend/Share
₹1.00
Ex DateEx Date
Mar 11, 2020
Cash Dividend
Ex DateEx DateAug 1, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Aug 1, 2019
NH Stock News & Opinions
Profit before tax stood at Rs 253.02 crore during the quarter, registering a growth of 13.86% from Rs 222.22 crore reported in Q4 FY24. India's revenue stood at Rs 1,108.8 crore, up 10.66% year-on-year (YoY), while revenue from the Cayman Islands was Rs 379.7 crore, up 50.2% YoY. Consolidated EBITDA grew by 22.17% to Rs 384.6 crore in the March 2025 quarter from Rs 314.8 crore in Q4 FY24. EBITDA margin improved to 26.1% in Q4 FY25 as against 25.3% in Q4 FY24. On the margins front, the company's operating margin reduced to 24.25% in Q4 FY25, compared with 23.02% recorded in Q4 FY24. Net profit margin declined to 13.30% in Q4 FY25 from 14.91% registered in Q4 FY24. As of March 31, 2025, the company's total borrowings, net of cash, bank balances, and current investments, stood at Rs 533 crore. The net debt-to-equity ratio was at 0.15, with foreign currency-denominated debt amounting to $86.8 million. On a full-year basis, the company's net profit rose 0.11% to Rs 790.16 crore on a 12.12% rise in revenue to Rs 5,482.98 crore in FY25 over FY24. Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said, 'The current financial year demonstrated strong performance across our units, both domestic and international; we are pleased to report the highest-ever revenues and profitability margins on both a quarterly and an annual basis at the consolidated level. The performance improvement in India units has been driven by domestic volume pickup, increased realizations, and optimization in payor categories. While our flagships continue to contribute significantly, our Southern Peripheral and North units have shown significant growth this year, and we hope to build on the momentum going forward. The new hospital in Camana Bay is fully functional and is contributing meaningfully to the overall Cayman business. We are excited about the traction in the new hospital and are confident that the region will deliver strong growth going forward. The integrated care business is picking up well, with our new clinics garnering sizeable footfalls. We will continue to invest in this business and are optimistic that it will be a significant driver of growth for the overall NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the upcoming year.' Meanwhile, the board has recommended a final dividend of Rs 4.50 per equity share for the financial year ended March 31, 2025. The record date for determining eligible shareholders has been set as Friday, 1 August 2025. Additionally, the board approved a proposal to seek shareholder approval via special resolution to raise up to Rs 1,500 crore in a financial year through the issuance of debt securities, including non-convertible debentures (NCDs), in one or more tranches on a private placement basis. The securities may be denominated in Indian rupees or foreign currency. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 2 heart centers across India, along with an overseas presence in the Cayman Islands, with over 5,550 operational beds and a capacity of over 5,900 beds.Powered by Capital Market - Live
Narayana Hrudayalaya announced that the 25th Annual General Meeting(AGM) of the company will be held on 29 August 2025.Powered by Capital Market - Live
Narayana Hrudayalaya announced that the Board of Directors of the Company at its meeting held on 23 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Narayana Hrudayalaya rose 3.41% to Rs 197.21 crore in the quarter ended March 2025 as against Rs 190.71 crore during the previous quarter ended March 2024. Sales rose 18.39% to Rs 1475.44 crore in the quarter ended March 2025 as against Rs 1246.25 crore during the previous quarter ended March 2024. For the full year,net profit rose 0.11% to Rs 790.16 crore in the year ended March 2025 as against Rs 789.26 crore during the previous year ended March 2024. Sales rose 12.12% to Rs 5482.98 crore in the year ended March 2025 as against Rs 4890.21 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1475.441246.25 18 5482.984890.21 12 OPM %24.2523.35 -23.2823.47 - PBDT343.88286.74 20 1222.011125.47 9 PBT261.38222.22 18 943.90883.99 7 NP197.21190.71 3 790.16789.26 0 Powered by Capital Market - Live
Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
Kammavari Sangham will set-up hospital infrastructure with capacity of 110 beds in the Bengaluru South region. The project is expected to commence operations in the FY 2026-27. Under the terms of the agreement, Kammavari Sangham shall provide hospital facility to Narayana Hrudayalaya in the Bengaluru South region on a long-term basis. The company would run and operate the said hospital as per the terms of the agreement. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company's consolidated net profit increased 2.6% to Rs 192.94 crore in Q3 FY25 as compared with Rs 188.02 crore in Q3 FY24. Net sales jumped 13.5% YoY to Rs 1366.68 crore during the quarter ended 31st December 2024. The scrip had gained 0.76% to end at Rs 1677.90 on the BSE on Friday. Powered by Capital Market - Live
Narayana Hrudayalaya has entered into an operation and management agreement with M/s. Kammavari Sangham, a registered Society under the Karnataka Societies Registration Act 1960 to govern the operation, maintenance, overall management of the hospital to be built by M/s. Kammavari Sangham and to provide healthcare services. The purpose of the agreement is to set-up hospital infrastructure to be run and operated by Narayana Hrudayalaya with capacity of 110 beds in the Bengaluru South region. The Project is expected to commence operations in the FY 2026-27.Powered by Capital Market - Live
The joint venture agreement aims to establish and operate a network of healthcare centers in India, specifically for the treatment of cancer patients, with a focus on chemotherapy treatment through the JV company. 2070 Health Inc. and W Health Ventures GP LLC are both incorporated under the laws of Delaware, USA while Everhope Oncology Private, is the joint venture company. The equity subscription by parties will take place in three tranches over a period of time, HCCI will hold 50%, 2070 Health will hold 20% and W health Ventures GP LLC will hold 30% of the shareholding. The company said that the total investment over a period of next 1 to 2 years is expected to be $10 million. Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company's consolidated net profit increased 2.6% to Rs 192.94 crore in Q3 FY25 as compared with Rs 188.02 crore in Q3 FY24. Net sales jumped 13.5% YoY to Rs 1366.68 crore during the quarter ended 31st December 2024.Powered by Capital Market - Live
Gland Pharma Ltd, CreditAccess Grameen Ltd, Tata Investment Corporation Ltd, Adani Power Ltd are among the other stocks to see a surge in volumes on NSE today, 25 February 2025.Narayana Hrudayalaya Ltd notched up volume of 43.73 lakh shares by 14:14 IST on NSE, a 13.11 fold spurt over two-week average daily volume of 3.33 lakh shares. The stock rose 6.01% to Rs.1,477.00. Volumes stood at 2.8 lakh shares in the last session.Gland Pharma Ltd registered volume of 12.91 lakh shares by 14:14 IST on NSE, a 8.49 fold spurt over two-week average daily volume of 1.52 lakh shares. The stock rose 4.68% to Rs.1,596.80. Volumes stood at 3.48 lakh shares in the last session.CreditAccess Grameen Ltd recorded volume of 75 lakh shares by 14:14 IST on NSE, a 5.71 times surge over two-week average daily volume of 13.14 lakh shares. The stock gained 2.66% to Rs.876.20. Volumes stood at 10.38 lakh shares in the last session.Tata Investment Corporation Ltd recorded volume of 12.46 lakh shares by 14:14 IST on NSE, a 5.65 times surge over two-week average daily volume of 2.21 lakh shares. The stock gained 6.41% to Rs.6,123.95. Volumes stood at 72078 shares in the last session.Adani Power Ltd witnessed volume of 184.56 lakh shares by 14:14 IST on NSE, a 5.41 times surge over two-week average daily volume of 34.15 lakh shares. The stock increased 7.82% to Rs.506.85. Volumes stood at 19.26 lakh shares in the last session.Powered by Capital Market - Live
Net profit of Narayana Hrudayalaya rose 2.62% to Rs 192.94 crore in the quarter ended December 2024 as against Rs 188.02 crore during the previous quarter ended December 2023. Sales rose 13.55% to Rs 1366.68 crore in the quarter ended December 2024 as against Rs 1203.64 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1366.681203.64 14 OPM %22.4623.17 - PBDT288.79271.77 6 PBT218.82208.59 5 NP192.94188.02 3 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.1%, vs industry avg of 10.01%
Over the last 5 years, market share increased from 7.84% to 8.01%
Over the last 5 years, net income has grown at a yearly rate of 67.89%, vs industry avg of 42.91%